Multus is a global leader in cell culture media design for cell-based biomanufacturing, combining AI, robotic automation, and cell biology.
Multus has raised $9.5M in total funding. The most recent round was Series A. The last funding was announced in January 2023.
Multus's investors include Big Idea Ventures, Zero Carbon Capital, SOSV, Innovate UK, SOSV SF & NY (Fka IndieBio).
Multus is headquartered in London, United Kingdom.
Multus is a global leader in cell culture media design for cell-based biomanufacturing, combining AI, robotic automation, and cell biology.
Multus is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Multus — Funding & Investors." VCBacked, January 16, 2023, https://www.vcbacked.co/company/multus. Accessed August 13, 2026.
VCBacked. (2023). Multus — Funding & Investors. Retrieved August 13, 2026, from https://www.vcbacked.co/company/multus
{{cite web |title=Multus — Funding & Investors |url=https://www.vcbacked.co/company/multus |website=VCBacked |access-date=August 13, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated